OPYT PRIMENENIYa DIENOGESTA V KOMBINIROVANNOM LEChENII GENITAL'NOGO ENDOMETRIOZA
- Authors: Yarmolinskaya M.I1, Bezhenar' V.F1
-
Affiliations:
- Issue: No 3 (2013)
- Pages: 48-51
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/280285
- ID: 280285
Cite item
Open Access
Access granted
Abstract
The article presents the results of the evaluation of the efficacy and tolerability of dienogest in the combined treatment of 176 patients with external genital endometriosis and patients with associated hyperplastic processes in other organs of reproductive system. It is shown that dienogest at a dose of 2 mg is effective in the treatment of endometriosis, significantly reduces the severity of pain, and can be used for a long time; dienogest should be considered as the drug of choice for patients with recurrence of disease.
Full Text
References
- Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Эндометриоидная болезнь СПб., 2002. 452 с.
- Kennedy S, Bergqvist A, Chapron C, et at; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;20(10):2698-704.
- Ярмолинская М.И. Генитальный эндометриоз: влияние гормональных, иммунологических и генетических факторов на развитие, особенности течения и выбор терапии. Дисс. докт. мед. наук. СПб., 2009. 40 с.
- Practice Committee of American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2008;90(5 Suppl):S260-69.
- Winkel CA, Scialli AR. Medical and surgical therapies for pain associated with endometriosis. Womens Health Gend Based Med 2001;10(2):137-62.
- ESRHE guideline. http://guidelines.endome-triosis.org/pain.html. 2007.
- Vercellini P, Fedele L, Pietropaolo G, et al. Progestogens for endometriosis: forward to the past. Hum Reprod Update 2003;9(4):387-96.
- Fenton А, Panay N. Does routine gynecological surgery contribute to an early menopause? Climacteric 2012;15(1):1-2.
- Oettel M, Carol W, Elger W. A 19-norprogestin without 17β-ethinyl group II: dienogest from a pharmacodynamic point of view. Drugs Today 1995:31:517-36.
- Sasagawa S, Shimizu Y, Kami H, et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008;73:222-31.
- McCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs 2010;70(16):2073-88.
- Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25:633-41.
- Momoeda M, Taketani Y. Randomized doubleblind, multicentre, parallel-group dose-response study of dienogest in patients with endometriosis. J Pharmacol Ther 2007;35:769-83.
Supplementary files
